Current Report Filing (8-k)

Date : 06/07/2019 @ 10:05PM
Source : Edgar (US Regulatory)
Stock : Actinium Pharmaceuticals (Delaware) (ATNM)
Quote : 0.2387  0.0035 (1.49%) @ 1:00AM

Current Report Filing (8-k)

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 7, 2019

 

ACTINIUM PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   000-52446   74-2963609
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

275 Madison Avenue, 7th Floor
New York, NY
  10016
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (646) 677-3870

 

N/A
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol     Name of exchange on which registered
Common stock, par value $0.001   ATNM   NYSE American

  

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

   

 

 

Item 8.01 Other Events

 

As of March 31, 2019, Actinium Pharmaceuticals, Inc.’s (the “Company”) stockholders’ equity was below $6 million, the minimum required for continued listing on the NYSE American pursuant to Section 1003(a)(iii) of the NYSE American Company Guide since the Company has incurred losses in its five most recent fiscal years. However, subsequent to March 31, 2019 and as of the date of filing of the Form 10-Q for the quarterly period ended March 31, 2019 that was filed with the Securities and Exchange Commission on May 10, 2019, the Company’s stockholders’ equity was above $6 million as a result of the closing of a public offering in April 2019. The Company sold 42.9 million shares of common stock at an offering price of $0.385 per share and warrants to purchase up to 42.9 million shares of common stock at an exercise price of $0.50 per share and with a term of 5 years, resulting in gross proceeds of $16.5 million and net proceeds of $15.1 million after deducting underwriting and other offering expenses. The financing added $15.1 million to stockholders’ equity.

 

  1  

 

 

Dated: June 7, 2019 ACTINIUM PHARMACEUTICALS, INC.
     
  By: /s/ Sandesh Seth
  Name: Sandesh Seth
  Title:   CEO & Chairman

 

 

  2  

 

Actinium Pharmaceuticals, Inc. (AMEX:ATNM)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more Actinium Pharmaceuticals, Inc. Charts.

Actinium Pharmaceuticals, Inc. (AMEX:ATNM)
Intraday Stock Chart

Today : Saturday 20 July 2019

Click Here for more Actinium Pharmaceuticals, Inc. Charts.

Latest ATNM Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.